Oncology clinical trials present unique challenges for collecting, analyzing and interpreting patient-reported outcome (PRO) data. Join us as our panel of experts discuss these challenges and outline some solutions to overcome them.
- The specific challenges associated with data analysis from oncology studies.
- Why traditional statistical methods for clinical trials can lead to biased results when applied to oncology studies.
- Possible analytic methods to help account for potential biases and help you better understand your patients.
- Why safety and patient-reported outcome endpoints may appear contradictory in oncology trials.